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Two contrasting theories have emerged that attempt to describe
T-cell ligand potency, one based on the t1/2 of the interaction and
the other based on the equilibrium afﬁnity (KD). Here, we have
identiﬁed and studied an extensive set of T-cell receptor (TCR)-
peptide-MHC (pMHC) interactions for CD4+ cells that have differ-
ential KDs and kinetics of binding. Our data indicate that ligands
with a short t1/2 can be highly stimulatory if they have fast on-
rates. Simple models suggest these fast kinetic ligands are stimu-
latory because the pMHCs bind and rebind the same TCR several
times. Rebinding occurs when the TCR-pMHC on-rate outcompetes
TCR-pMHC diffusion within the cell membrane, creating an aggre-
gate t1/2 (ta) that can be signiﬁcantly longer than a single TCR-
pMHC encounter. Accounting for ta, ligand potency is KD-based
when ligands have fast on-rates (kon) and t1/2-dependent when
they have slow kon. Thus, TCR-pMHC kon allow high-afﬁnity short
t1/2 ligands to follow a kinetic proofreading model.
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T cell receptors (TCRs) expressed on T cells bind host MHCproteins presenting both self- and foreign pathogen-derived
peptides (pMHCs). Depending on the signal emanating from
these interactions, diverse biological outcomes ensue. In the
thymus, these TCR-pMHC-mediated signals shape the speciﬁcity
of the mature T-cell repertoire and prevent overtly self-reactive
T cells from escaping (1). In the periphery, naive T cells require
continual TCR engagement with self-pMHC complexes to re-
ceive a homeostatic survival signal, whereas engagements with
foreign peptides induce rapid T-cell division and the acquisition
of effector functions (2). How T cells interpret the interaction
between their TCR and pMHC ligands leading to these different
biological outcomes is greatly debated.
Two competing models of T-cell activation have been pro-
posed, with ligand potency being a function of TCR-pMHC
equilibrium afﬁnity (KD) (3–7) or t1/2 (8–11). Evidence sup-
porting KD-based receptor occupancy models of TCR signaling
comes from sets of ligands that show a correlation between the
KD and ligand potency (3, 5) and from the fact that ligands in-
duce qualitatively distinct biological outcomes depending on
their concentration (12).
In sharp contrast to receptor occupancymodels, t1/2-based kinetic
proofreading models hypothesize that the TCR must be engaged
long enough to complete a series of signaling events, including cor-
eceptor recruitment andTCRphosphorylation (13). Increases in the
t1/2 of the TCR-pMHC engagement raise the probability that any
singleTCR-pMHCengagementwill surpass the thresholdamountof
time required to initiate T-cell activation (14). Recently, this thresh-
old amount of time has been predicted to be at least 2 s (9, 15).
Whether there is, in addition, an optimal t1/2 that balances these
kinetic proofreading requirements and the serial triggering of TCRs
has been debated (16, 17).
Further evidence supporting t1/2-based kinetic proofreading
models arises from the discovery of antagonist pMHC ligands
(18). TCR antagonists induce partial but not complete phos-
phorylation of the TCR complex and fail to activate T cells fully
at any ligand concentration (18). The subsequent discovery that
antagonist ligands bind TCRs with a shorter t1/2 than stimulatory
agonist-pMHC complexes further suggests that activating ligands
must engage a speciﬁc TCR for a long enough period to allow
a series of signaling events to occur (19, 20).
As compelling as the arguments are for t1/2 models of T-cell
activation, discoveries of highly potent T-cell ligands with a short
t1/2 suggest that T-cell activation may not be solely dependent on
the dwell time (4–6, 21, 22). In an attempt to reconcile why
neither KD nor t1/2 fully predicts ligand potency, we have iden-
tiﬁed low-, medium-, and high-potency T-cell ligands that have
medium and fast binding kinetics. The potency of these ligands
fails to be described by either a KD or t1/2-based model. By
mathematically modeling the biophysical mechanisms leading to
T-cell activation using standard assumptions, our results indicate
that fast kon allow an individual TCR to bind and rebind rapidly
to the same pMHC several times before diffusing away. The
rebindings lead to an aggregate t1/2 (ta) that can be signiﬁcantly
longer than individual TCR-pMHC interactions. Importantly,
ligand potency correlates closely with this ta regardless of
whether the ligands have fast or slow kon or t1/2s. These ﬁndings
demonstrate that KD and t1/2 models of T-cell activation are not
mutually exclusive, because both emerge from a ta model. In
particular, the ta depends on the t1/2 or KD alone when kon
are low or high, respectively. The ta allows strong KD/fast-
binding kinetic ligands to follow a kinetic proofreading model
of activation.
Results
Identiﬁcation of High, Medium, and Low KD TCR–pMHC Interactions
with Fast Rates of Association and Disassociation. During our pre-
vious study of TCRs speciﬁc for IAb/3K, we noticed that several
of these TCRs bound IAb/3K with a strong KD using very fast
binding kinetics (22, 23). However, because some of the koff were
exceptionally fast, with loss of all speciﬁc binding for some oc-
curring in less than 1 s, the original measurement had a signiﬁ-
cant error range. Using surface plasmon resonance (SPR)
focusing on obtaining TCR-pMHC disassociation rates, we
measured the binding kinetics of the B3K506 and B3K508 TCRs
interacting with the previously reported and additional IAb/3K
altered peptide ligands (APLs) (Fig. 1).
Although the B3K506 and B3K508 TCRs interact with the
IAb/3K complex with a conventional KD for agonist ligands
(7 μM for the B3K506 and 29 μM for the B3K508), the binding
kinetics of the interaction of the B3K506 TCR with IAb/3K are
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extremely fast: kon = 101,918/M·s and koff = 0.7/s, leading to
a t1/2 of 0.9 s (Fig. S1 and Table S1). The KDs of other B3K506
and B3K508 TCR ligands range from 7–175 μM, all with fast or
medium binding kinetics.
B3K506 and B3K508 CD4 T Cells Proliferate in Response to High,
Medium, and Low KD Ligands with a Very Short t1/2. To determine
the potency of high, medium, and low KD ligands with differing
binding kinetics, mature CD4 T cells from B3K506 and B3K508
Rag1−/− TCR transgenic (Tg) mice were incubated with titrating
concentrations of peptides and assessed for proliferation (Fig. 2).
Because the peptides with a KD or t1/2 beyond the SPR detection
limit failed to induce signiﬁcant activation, we do not consider
them in our subsequent analysis. Of critical importance, except
for a 2-fold increase in binding by the 3K P2A peptide to IAb, the
peptides all bind similarly to IAb proteins (24). Furthermore,
mature B3K506 and B3K508 CD4 T cells are equally sensitive to
anti-CD3-mediated T-cell signaling, suggesting that the respon-
ses of these different T cells to stimulatory ligands can be directly
compared (Fig. S2). Our data conﬁrm that fast kinetic ligands
can signal, suggesting that the 2-s limit on t1/2 is not absolute.
Notably, the B3K506 undergoes proliferation at submicromolar
peptide concentrations by the 3K, P5R, P8R, and P-1A ligands
(t1/2 = 0.9, 0.9, 0.8, and 0.3 s, respectively) (Table S1).
Some T-cell ligands with a shorter t1/2 than the immunizing
ligand can induce superagonist or partial T-cell effector func-
tions if the TCR complex is not efﬁciently ubiquitinated (18, 25).
To determine whether B3K506 and B3K508 T cells undergo
complete activation in response to fast kinetic ligands, we chose
two additional cellular functions to explore: (i) ligand-induced
TCR down-regulation as a measure of receptor phosphorylation,
ubiquitination, and degradation by Cbl-b (26) and (ii) cytokine
production by T cells. Consistent with inducing complete phos-
phorylation of the TCR complex and T-cell activation, fast ki-
netic ligands induce TCR down-regulation and TNF-α
production (Fig. S3 and Table S1).
Ligand Potency of 3K or APLs Fails to Obey Straightforward KD or t1/2
Model. Individually, ligand potency for the B3K506 or B3K508 T
cells loosely follows the overall trend of both KD- and t1/2-based
models. However, when B3K506 and B3K508 T-cell activation
data are compared, neither model sufﬁces (Fig. 3 and Table S1).
In regard to KD, the B3K508 T cells are hyperresponsive. For
example, the 3K ligand induces proliferation of B3K506 and
B3K508 T cells at a similar nanomolar range concentration, de-
spite having signiﬁcantly different KDs (7 vs. 29 μM). In another
example, the B3K506 TCR binds IAb/P-1A (26 μM) with a sim-
ilar KD as the B3K508 TCR binding IA
b/3K (29 μM), yet the
B3K506 T cells proliferate at an EC50 that is 23-fold less than
that of the B3K508 T cells. A failure of KD to deﬁne the ligand
potency is further apparent when additional 3K APLs are tested
(Fig. 3A and Table S1).
In reverse correlation from KD, ligand potency does not cor-
relate with t1/2 because the B3K506 T cells are hyperresponsive.
Fig. 1. Release of soluble IAb/3K and APLs from immobilized B3K506 or B3K508 TCR, monitored SPR. Soluble IAb/3K, P5R, P8R, or P-1A (A); P8A, P5Q, or P-1K
loaded onto B3K506 TCRs (B); or IAb/3K, P5R, or P2A loaded onto B3K508 TCRs (C) was allowed to disassociate for 60 s at a ﬂow rate of 20 μL/min at 25 °C. Data
were collected at 0.2-s intervals and ﬁt to a 1:1 Langmuir binding model to determine the dissociation rate (koff) and t1/2 of the MHC/TCR complex. Curves are
examples of three independent experiments.
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Fig. 2. Activation of 3K-reactive T cells to differing KD ligands. B3K506 (A) and B3K508 (B) T cells proliferate when challenged with 3K and APLs. 3K APLs are
listed next to each panel by decreasing KD. Data are representative of at least three independent experiments.
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The 3K ligand induces similar proliferation of the B3K506 T
cells (t1/2 = 0.9 s) as the B3K508 T cells (t1/2 = 2.2 s) (Table S1).
In addition, the P5R ligand is signiﬁcantly less potent in acti-
vating the B3K508 T cells than the 3K ligand is in activating the
B3K506 T cells, despite having a similar t1/2 (0.7 and 0.9 s, re-
spectively). Multiple discrepancies can be observed when com-
paring other 3K APLs (Fig. 3B and Table S1). The ﬁnding that
each T cell in isolation loosely follows both KD- and t1/2-based
models appears to be an artifact of limited variation in the ki-
netics among the ligands for each T cell. A failure of KD or t1/2 to
predict ligand potency is true for cytokine production as well,
suggesting that the proliferation response is not anomalous (Fig.
S3 and Table S1).
Consistently, activating ligands for B3K506 T cells use a fast
kon or strong KD to compensate for a short t1/2. (Because there is
a simple relation among them, only two of the three parameters
describing the interaction are independent.) Vice versa, B3K508
T cells compensate for a weak KD by engaging IA
b/3K ligands for
a longer t1/2. These results suggest that ligand potency is de-
termined by an interplay between the TCR-pMHC kon and t1/2
(or KD and t1/2) in a way that allows for enhanced signaling by
fast kinetic ligands.
Does a Combined KD/t1/2 Model or Serial Triggering Predict T-Cell
Ligand Potency? In an attempt to reconcile how the interplay of
KD and binding kinetics inﬂuences T-cell activation, we evalu-
ated whether straightforward merging of the two predicts ligand
potency. A combined KD and t1/2 model suggests that increasing
the frequency or total number of TCRs engaged by pMHCs
would stochastically result in an increase in the number of un-
characteristically long TCR-pMHC interactions. To test this, we
identiﬁed the change in receptor occupancy required for a strong
KD fast kinetic ligand to be bound to an equal number of TCRs,
on average, for at least 2 s as compared with a medium kinetic
medium KD ligand.
To approximate how frequently each pMHC ligand is bound to
a TCR, we assume that a quasiequilibrium between TCRs and
pMHCs occurs on the time scale of cell-cell contact and that TCRs
are far in excess of the relevant pMHCs. The probability that
a pMHC is bound to a TCR then depends on the equilibrium as-
sociation afﬁnity (KA) through a simple saturation curve (3):
cpMHC−TCR
c0pMHC
¼ KAc
0
TCR
1þ KAc0TCR
[1]
The parameter c0pMHC denotes the concentration of pMHCs on the
antigen presenting cell (APC), c0TCR denotes the concentration of
TCRs in the interface, and cpMHC-TCR denotes the concentration
of bound pMHC. c0TCR was estimated to be 20 TCRs per square
micrometer (10,000 TCRs per T cell per 500-μm2 surface area of
a T cell; SI Text). Within TCR islands, c0TCR can be locally much
higher (80–430 per square micrometer) (27); however, increasing
this value had little effect on our results. To convert the measured
KA of the TCR-pMHC pair in solution to KA when the TCRs and
pMHCs aremembrane-bound, we have used a conﬁnement length
measured for the 2B4TCR interactingwith theMCC88-103 ligand
(1.2 nm, corresponding to a conversion factor of 0.262 nm) (8).
The TCR-pMHC saturation curve from Eq. 1 contains
a threshold KD, K*, above which pMHC ligands are bound at
least 50% of the time. Using the above approximations, K* is 130
μM and pMHC ligands with a 43-μM KD are bound 75% of the
time (Fig. 4). These values mirror measurements made by Gra-
koui et al. (8), in which the majority of a 60-μM KD pMHC li-
gand was bound to a TCR when located within the interface of
T cells and APCs. As a result of ligand saturation, strengthening
KD above 100 μM has only a modest effect on the overall fre-
quency of TCRs bound to pMHCs. This saturation curve can be
used to show that changes in TCR-pMHC occupancy do not
describe ligand potency (SI Text).
By comparing ligands with similar EC50s of proliferation yet
different t1/2s, we tested whether a merged KD/t1/2 model
describes ligand potency. Speciﬁcally, the tests evaluate whether
a stronger KD for the B3K506 TCR engaging the pMHC gen-
erates enough additional bindings to overcome the lower prob-
ability of the bindings being long-lived. One comparison is the
B3K506 TCR interacting with 3K/P-1A peptide (KD = 26 μM,
t1/2 = 0.3 s, EC50 = 9 nM) and the B3K508 TCR interacting with
the 3K/P5R peptide (KD = 93 μM, t1/2 = 0.7 s, EC50 = 15 nM).
Assuming that TCRs bind pMHCs with exponentially distributed
dwell times, the B3K506 TCR would have to bind 26-fold more
IAb/P-1A ligand than the B3K508 TCR binding IAb/P5R to
generate an equal number of 2-s engagements. However, the
3.6-fold difference in KD between the two TCR-pMHC pairs
leads to only a 1.5-fold difference in receptor occupancy. The
effect is qualitatively similar for other comparisons (Fig. S4A)
and is largely robust to assumptions about the parameters
(SI Text). Thus, a merged KD/t1/2 model does not properly ac-
count for ligand potency. Based on similar reasoning, the effects
of serial triggering cannot contribute signiﬁcantly to ligand po-
tency (Fig. S4 B and C and SI Text). It appears that the roles of
the kon and KD in our data are not to increase the number of
bindings, either at any given time (receptor occupancy) or over
time (serial triggering).
Could Rebinding of TCRs to pMHCs Expand the Dwell Time for Fast
Kinetic Ligands? The failure of KD, t1/2, or serial triggering models
indicates that other mechanisms must underlie ligand potency.
Fig. 3. Failure of KD or t1/2-based models to predict ligand potency. EC50
values, based on proliferation, are shown with respect to KA (A) and t1/2 (B).
Data points are labeled by T cell, B3K506 (squares) or B3K508 (circles) and
grouped by ligand potency: highest (black), intermediate (gray), and lowest
(white). Speciﬁc TCR-pMHC pairs are listed to the right, ordered according to
EC50. The EC50 values are averaged over three measurements.
Fig. 4. Receptor occupancy depends only weakly on KD for pMHC ligands
with a KD stronger than 130 μM. The receptor occupancy predicted by Eq. 1 is
plotted, according to the parameter estimates in the text, on a scale that is
linear in KA (1/KD). The predictions for the actual pMHC-TCR pairs in our
experiments are superimposed on the plot (circles), colored (black, gray, or
white) according to their actual activity as described in the legend for Fig. 3.
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The hypothesis of serial triggering, that individual pMHCs can
sequentially bind multiple TCRs, led us to wonder whether
a pMHC can bind multiple times to the same TCR. The ability of
a receptor/ligand pair to associate, disassociate, and reassociate
in a ﬁnite amount of time before complete disengagement is
termed “rebinding.” Although TCR-pMHC interactions are
usually thought of as single binding events, it is theoretically
possible that ligands with fast kon may be able to rebind TCRs
(28), especially because they are bound on membranes on which
diffusivities are typically slower than in solution. If it occurred,
TCR-pMHC rebinding would generate an aggregate dwell time
(ta) of interaction, assuming that the rebindings occur faster than
the TCR signaling complex disassembles.
To investigate whether TCR-pMHC rebindings are plausible,
we have followed an extensive set of work analyzing diffusion-
inﬂuenced reactions (29, 30). Our approach has been to apply
the particular estimate of the ta, including rebindings, as pro-
vided by Bell (31), because of its simplicity and to suggest that
the qualitative results are robust to the choice of model (see
below and SI Text). In applying Bell’s model (31), we assume that
pMHCs and TCRs move purely diffusively on ﬂat stiff mem-
branes. Neglecting membrane forces is potentially in conﬂict
with emerging work indicating the role of the actin cytoskeleton
in breaking TCR-pMHC bonds, decreasing their t1/2 (32).
However, when kon are fast enough for rebinding to occur, they
happen very quickly; thus, it is unclear how much membrane
forces could intervene.
The model also assumes that all rebindings occur at the same
rate, which neglects any stabilization of binding that may be
provided by coreceptors. Stabilization would have the effect of
increasing the propensity of rebinding. Furthermore, the model
counts only those rebindings that occur almost immediately,
before the TCR and pMHC separate by more than a molecular
length scale (e.g., 100 Å), on the order of 1 ms using the
parameters below. Although the molecular details of TCR acti-
vation are not entirely understood (33, 34), TCR activation is not
expected to be appreciably reversed on such short time scales.
Within this framework, Bell’s result (31) for the total dwell
time, summing the duration of any rebindings that occur, is:
ta ¼ t1=2 þ

lnð2Þ
2π

DTCR þDpMHC


·KA [2]
The parameters DTCR and DpMHC represent the diffusivities of
TCR and pMHC, respectively. From Bell’s result (31), it can be
seen that the ta is dependent on the individual t1/2 and KD. The
ﬁrst term in Eq. 2 accounts for the duration of the ﬁrst binding,
whereas the second afﬁnity-dependent term accounts for any
subsequent rebindings. Noting that every individual binding
event lasts, on average, as long as any other, the expected
number of rebindings between a particular pMHC-TCR pair is:
N ¼ kon
2π

DpMHC þDTCR
 [3]
The parameter kon denotes the on-rate of the pair on the
membrane. The system has qualitatively different dependence on
t1/2 and KD when kon are small and large. When kon are fast
relative to the diffusion rates, pMHC binds and rebinds the same
TCR many times, reaching a quasiequilibrium before diffusing
away. As a result, the KD dominates the duration of the in-
teraction when kon are high. However, when kon are slow,
rebinding does not occur and t1/2 dominates. Because Eq. 2 can
be independently motivated by simple arguments such as these, it
is qualitatively robust to the choice of model (SI Text).
More generally, Eq. 3 suggests that there is a threshold kon
above which rebindings are relevant:
kon ¼ 2π

DTCR þDpMHC

[4]
Whenever the kon exceeds this threshold (Eq. 4; also known as
the diffusion-limited rate), at least one rebinding is expected to
occur. Importantly, the speciﬁc parameter values are important
only insofar as they inﬂuence this threshold and not the un-
derlying biophysical event (Figs. S5 and S6).
Rebinding of TCRs to pMHCs Uniquely Explains How Fast Kinetic
Ligands Induce T-Cell Activation. To evaluate whether rebinding
could have an impact on the dwell time of B3K506 or B3K508
TCRs engaging pMHC ligands, we applied Eq. 2 to our dataset.
The diffusivities for a TCR and pMHC were estimated at 0.04 and
0.02 μm2/s, respectively, corresponding to midrange measured val-
ues (SI Text). On-rates measured using SPR were converted to kon
on the membrane by assuming (i) that koff of membrane-bound
TCRs binding pMHCs are identical to SPR measurements and (ii)
that the KDs of membrane-bound TCRs engaging pMHCs are
proportional to SPR-measured afﬁnities, as done in our analysis of
receptor occupancy. Because of limited data, it is generally difﬁcult
to convert SPR-measured kon directly to kon on the membrane (35,
36). We discuss sensitivity to the assumptions in SI Text.
Using these parameter values, rebinding likely occurs for
TCR-pMHC pairs with fast binding kinetics (Fig. 5). Speciﬁ-
cally, this initial model predicts that the threshold on-rate for
rebinding is 60,000/M·s. As a result, the expected number of
rebindings increases from almost none to 1.7 as the on-rate
increases in our sample from 11,000/M·s to 102,000/M·s. Because
T-cell activity is generally thought to be very sensitive to t1/2,
a factor of 2 or 3 can be important. When rebindings are
accounted for, the highly potent B3K506 T-cell ligands 3K, P5R,
and P8R change from a t1/2 of 0.9 or 0.8 s to tas of 2.7, 1.9, and
1.8 s and the medium potent P-1A ligand converts from a t1/2 of
0.27 s to a ta of 0.72 s. Importantly, the ta is signiﬁcantly better
at predicting ligand potency than the KD or t1/2 (Fig. 6C and
Figs. S4, S7, and S8).
Within the dataset, two groups of high- or medium-potency
ligands arise from different TCR-pMHC binding parameters
(Table S1). Using these groups, the competing models can be
quantitatively evaluated. The four high-potency ligands (3K,
P5R, and P8R binding the B3K506 TCR and 3K binding the
B3K508 TCR) have KDs and t1/2s that vary widely by factors of
4.0 and 2.7, but tas that vary only by a factor of 1.5 (Fig. 6C). The
two ligands in the second most potent group (B3K506 TCR
binding P2A and B3K508 TCR binding P5R) have KDs and t1/2s
that vary by factors of 3.6 and 2.6, respectively, but tas that are
almost identical, varying only by a factor of 1.1.
Although our ta model was generated without empirically ﬁt-
ting the data, our estimate for the rebinding threshold, 60,000/
M·s, is near the best ﬁt for minimizing the variation in the tas of
the most potent group of ligands (Fig. S5). Quite similarly, for
the medium-potent ligands, the best-ﬁt threshold is 45,000/M·s
(Fig. 6D). Convergence of the ta model with empirical data
suggests that the assumptions and underlying biophysical process
are correct.
Discussion
Binding of two proteins is governed by the KD, kon, and t1/2, any
two of which sufﬁce to describe the interaction because the three
are simply related. Although ligand potency could be dependent
on each of these binding characteristics, research over the past
two decades has suggested that only the KD or t1/2 matters.
Mechanistically, these two mutually exclusive models have been
interpreted to mean that T cells are either (i) sensitive to the
number of TCRs simultaneously bound to pMHC (3–6) or (ii)
sensitive to ligands that produce a long enough interaction to
phosphorylate the TCR complex fully (8–11, 13). In seeming
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contradiction to both theories, data presented here suggest that
neither the KD nor t1/2 determines the potency of T-cell ligands.
A plethora of data suggests that T cells are increasingly sen-
sitive to long-lived TCR-pMHC engagements, with a t1/2 of 2 s
being near the shortest allowable time (9, 15). Additionally,
T-cell responses are dependent on ligand concentration, sug-
gesting that T cells are also responsive to the frequency of these
long-lived bonds. With this as a starting point, we asked how
changes in the kon or KD might allow T cells to be equally re-
active to ligands with a different t1/2. The IA
b/3K model system is
particularly well suited for this analysis because each of the 3K
APLs binds IAb similarly and a relatively large number of TCR-
IAb/3K APL pairs contain several that have similar potency, al-
though using different KDs and binding kinetics. These con-
trolled combinations of T cells and pMHC ligands allowed
a direct comparison of the different theories of T-cell activation.
Because high-potency T-cell ligands with short t1/2s all have
fast kon, we hypothesized that TCR-pMHC interactions may be
inﬂuenced by diffusion rates. Although rebinding is potentially
relevant for any binding event, it will be less important for cy-
tosolic reactions because diffusivities in the cytoplasm are rela-
tively high (31). However, when both the receptor and ligand are
anchored on membranes, the rates of diffusion are drastically
reduced. A recent study of the interaction between membrane-
bound CD2 and CD58 using ﬂuorescence recovery after photo-
bleaching (FRAP) suggests that the fast-binding pair may rebind
100 times before separating, signiﬁcantly increasing the duration
of the bonds (37) and potentially explaining the pair’s physio-
logical activity (38).
Modeling TCR-pMHC interactions when both are mem-
brane-bound shows that fast kon allow rebinding to occur.
Depending on the kon, this effect can greatly extend bond
durations, allowing medium-potency ligands with measured t1/2s
of 0.3 and 0.7 s to generate a ta near 1 s. As an independent
example, the lymphocytic choriomeningitis virus-speciﬁc P14
TCR has been shown to bind its cognate H-2Db-gp33 ligand
with a low t1/2 of 0.7 s (21). Because of a fast kon of 400,000/M·s,
our rebinding model predicts that the P14 TCR would have a ta
of 5.5 s, which is fully consistent with kinetic proofreading
models of activation.
Most importantly, a rebinding-mediated ta uniquely predicts
ligand potency for B3K506 and B3K508 T cells (Fig. 6). Al-
though our data initially appear to be in conﬂict with both KD-
and t1/2-based activation models, the ta model is consistent with
reports that either t1/2 or KD can be the better predictor of ligand
potency. T-cell ligands with slow kon are predicted to follow
a strict t1/2-based reactivity pattern because rebinding does not
occur and the ta is equal to the t1/2 of a single binding event.
The canonical t1/2-dependent systems, such as the 2B4-IE
k/MCC
and 3L.2-IEk/Hb TCR-pMHC pairs, have slow kon compared
with the rebinding threshold we have estimated (45,000–60,000/
M·s) (10, 11). Because most T-cell activation studies have been
done using these systems, t1/2-based models have appeared suf-
ﬁcient and rebindings have not been required to understand
ligand potency. For example, the kon for the t1/2-dependent
2B4/MCC system studied by Krogsgaard et al. (10) are all less
than 6,670/M·s, such that almost no rebindings (<0.15) are pre-
dicted to occur.
In contrast to the canonical t1/2 models, most T-cell activation
studies suggesting that KD is a better predictor of ligand potency
have kon larger than or close to the rebinding threshold (5, 6).
Our data suggest that these correlations with KD occur because
Fig. 5. Fast kon lead to rebinding. (A) Average number of rebindings predicted by Eq. 3 is plotted vs. the kon. The threshold for rebinding, kon*, separates
pairs expected to rebind at least once from those that rarely rebind. (B) Probability of zero, one, two, three, or more than three rebindings between TCRs and
pMHCs, according to their on-rate, as predicted from Eq. 2 (SI Text).
Fig. 6. The ta is the best predictor of ligand potency for 3K-reactive T cells. EC50 values, based on proliferation, are shown with respect to KD (A), t1/2 (B), and
ta (C), with the rebinding threshold set at 60,000/M·s, and (D) ta, with rebinding threshold set at 45,000/M·s.
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of rebinding. For example, theKD dependence of the two peptides
studied by Ely et al. (6) is consistent with a dependence on the ta,
with the more potent peptide having a 14-fold faster kon and
a predicted 1.3- to 1.4-fold longer ta according to our model. Thus,
observations that ligand potency is dependent onKD or t1/2 are not
in conﬂict with each other; rather, they are different manifes-
tations of the interaction between the T cell andAPCwhen the kon
is very fast or very slow. With the continuing emergence of T-cell
ligands with very fast kon (4), our ﬁndings are likely to have an
impact on a large repertoire of T cells.
On completion of this work, we have become aware of results
for CD8+ T cells that are in harmony with our conclusions (39).
Materials and Methods
C57BL/6 mice were purchased from the Jackson Laboratory. Rag1−/− B3K506
and Rag1−/− B3K508 TCR Tg mice have been previously described (22). All
mice were maintained in a pathogen-free environment in accordance with
institutional guidelines in the Animal Care Facility at the University of
Massachusetts Medical School. Peptides were purchased from the Medical
Research Council at the National Jewish Medical Center. Additional details
are provided in SI Materials and Methods.
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SI Materials and Methods
T-Cell Proliferation. T-cell proliferation was assessed by incubating
1 × 105 naive Rag1−/− B3K506 or B3K508 CD4+ T cells for 48 h
with 5 × 105 irradiated C57BL/6 spleen cells and titrating
amounts of 3K or 3K variant peptides in 200 μL of RPMI, pulsed
with 1 microcurie of [3H]thymidine per well for 18 h, harvested,
and counted on a Wallac scintillation counter.
TCR Down-Regulation. In total, 1 × 105 B3K506 and B3K508
Rag1−/− CD4+ T cells were incubated with 5 × 104 bone marrow-
derived dendritic cells pulsed with titrating amounts of 3K or
variant peptides for 16 h in 200 mL of RPMI. Cells were then
washed and labeled with anti-TCR-β-FITC (HAM597), anti-
CD69-phycoerythrin, anti-CD4-peridinin chlorophyll protein,
and anti-Thy1.2-APC. TCR-β expression was assessed by ﬂow
cytometry (FACSCalibur; BD Biosciences) on CD4+ Thy1.2+
cells and analyzed using FlowJo version 8.3 (TreeStar).
Intracellular Cytokine Production. In total, 3 × 105 CD4 B3K506 or
B3K508 Rag1−/− CD4+ T cells were stimulated with 1 × 105
C57BL/6 bone marrow-derived dendritic cells pulsed with ti-
trating concentrations of 3K or variant peptides in the presence
of GolgiPlug (1 μL/mL; BD Biosciences) for 5 h at 37 °C. T cells
were then surface-stained with anti-CD4 and anti-CD8, washed,
ﬁxed in 4% (vol/vol) formaldehyde (Fischer Scientiﬁc), and
stained for intracellular TNF-α using a Cytoﬁx/Cytoperm kit (BD
Biosciences) in accordance with the manufacturer’s protocol.
TNF-α expression was assessed by ﬂow cytometry (FACSCali-
bur) on CD4+ T cells and analyzed using FlowJo version 8.3.
SPR Measurements of TCR-pMHC Kinetics and Afﬁnities. Soluble IAb/
3K and IAb/3K peptide variants were expressed and produced
using the baculovirus expression system, as previously described
(1, 2). KDs and binding kinetics for TCRs binding to IA
b/3K and
APLs were obtained on BIAcore 2000 and 3000 instruments
(BIAcore AB). Data points were collected at 0.2-s intervals and
analyzed with Bioeval 4.1 software (BIAcore AB). Scatchard
analyses of the equilibrium data were used to determine the
dissociation constant (KD). The kinetic data were used to de-
termine the dissociation rate (koff) and the association rate (kon)
were calculated from the KD and koff (kon = koff/KD).
Tests of Different Models of Ligand Potency and Sensitivity to Model
Parameters. Tests to determine whether T-ligand potency correlates with
TCR-pMHC occupancy when TCRs and pMHCs are membrane-bound. T-
cell ligand potency does not correlate with the measured KD (Fig.
3A). Even though the KD measurement of soluble proteins does
not describe ligand activity, it is possible that changes in receptor
occupancy when TCRs and pMHCs are membrane-bound do
describe our data. In this section, we provide an alternate ar-
gument against receptor-occupancy (KD)-based theories. In the
main text, we concluded that the affect of KD on receptor oc-
cupancy is weak because of saturation effects (Fig. 4). Thus, for
a KD-based model to explain the wide range of activities seen in
our dataset, the effect of receptor occupancy on activity would
have to be quite strong.
To assess directly whether changes in receptor occupancy can
account for ligand potency, we have compared two quantities: (i)
the dose–response of a T cell to different concentrations of li-
gand and (ii) the response of the T cell, at ﬁxed concentrations
of ligand, to ligands with different KDs. Because changes in
concentration and KD lead independently to changes in receptor
occupancy, the dose–response curves and the mutation studies
provide independent measures of the effect of receptor occu-
pancy on activity. By comparing KD-based changes in receptor
occupancy (comparing different ligands) with concentration-
based changes (comparing the same ligand at different concen-
trations), the impact of KD can be directly assessed. To do so, we
posited that changes in peptide concentration lead directly to
changes in receptor occupancy, assuming that TCRs are in great
excess and that the additional peptide binds MHC. For example,
we assume that a 2-fold increase in peptide concentration leads
to a 2-fold increase in pMHC-TCR engagement.
Consonant with our arguments against a pure KD theory in the
main text, the data indicate that the effect of receptor occupancy
on activity is not strong enough to explain our data. The dose–
response curves indicate that large changes in receptor occupancy
are required to increase activity, which are far larger than the
difference in receptor occupancies between two peptides with
different KDs. This can particularly be seen by examining the re-
sponses of the B3K506 TCR to two different peptides, IAb/3K and
IAb/P-1A. The IAb/3K peptide is more stimulatory for the
B3K506 TCR than for the IAb/P-1A peptide at every concentra-
tion of peptide. In particular, at a concentration of 0.0001 μM, the
3K peptide induces 14-fold more proliferation than the P-1A
peptide. The 3K peptide also has a stronger KD (7 and 26 μM,
respectively), in apparent agreement with a KD theory. Its 4-fold
higher afﬁnity can lead at most, however, to a 4-fold higher re-
ceptor occupancy at each concentration of peptide (Eq. 1). Be-
cause of saturation, the actual increase is probably less. In fact,
using estimates of relevant parameters, we predicted in the main
text that its receptor occupancy is only 12% higher than the re-
ceptor occupancy of the P-1A peptide (Fig. 4).
For the KD model to explain the differential activity of these
two peptides, a 4-fold increase in receptor occupancy must be able
to generate a 14-fold increase in proliferation. A 4-fold increase in
the concentration of P-1A from 0.0001 μM, however, barely in-
creases its proliferation (2-fold). In fact, the concentration of the
P-1A ligand must be increased over 50-fold to recapitulate the
activity of the 3K peptide at 0.0001 μM. Even if a 50-fold increase
in concentration leads to a smaller increase in receptor occupancy,
the gap is quite large.
Because the different afﬁnities in our dataset lead to only small
differences in receptor occupancy and peptide activity is not very
sensitive to receptor occupancy, KD theories do not explain our
data.
Testing the impact of serial triggering. Because neither KD nor t1/2
models, independently or combined, explained the T-cell acti-
vation data, we assessed whether serial triggering could inﬂuence
ligand potency. The serial triggering hypothesis postulates that
an individual pMHC can sequentially trigger multiple distinct
TCRs (3, 4). Thus, the faster on-rate of IAb/3K-binding B3K506
TCRs would lead to a greater number of distinct binding events
over the course of the T-cell-APC interaction. Serial triggering
of many more TCRs by fast kinetic ligands vs. slow kinetic li-
gands could lead to an increase in the probability of generating
uncharacteristically long-lived interactions.
To test whether serial triggering accounts for the ligand potency
of IAb/3K-reactive T cells, we determined how many more
binding events would be required for a strong KD and fast kinetic
ligand to bind an equal number of TCRs for at least 2 s as
a medium kinetic and medium KD ligand. We followed the
analysis conducted by Coombs et al. (5). In this model, the
number of distinct TCRs bound by a pMHC is as follows:
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N ¼ lnð2Þ
t1=2

KAcTCR
1þ KAcTCR

T
The parameter T denotes the total time a pMHC is present in
the APC-TCR interface. Because the number of distinct TCRs
a pMHC binds depends on the afﬁnity and kon in exactly the
same way as the receptor occupancy, the conclusion that serial
triggering also does not account for our data is not surprising.
As an example, we compared the responses of the fast kinetic
B3K506 TCR binding the IAb/P-1A ligand and the B3K508 TCR
binding IAb/P5R. These two peptides induce similar activity but
have different KD and binding kinetics. If we assume that TCRs
binding pMHC have exponentially distributed dwell times, as in
the main text, then to have a similar probability of engaging
pMHC for 2 s, the B3K506 TCR would have to generate 26-fold
more distinct binding events to the IAb/P-1A ligand than the
B3K508 TCR binding IAb/P5R. However, the 3.6-fold difference
in KD between the two TCR-pMHC pairs leads to only a 6.5-fold
difference in the in number of distinct bound TCRs. The impact
of serial triggering on equalizing t1/2s becomes worse when
a higher t1/2 threshold is assumed (Fig. S4C), further suggesting
that serial triggering cannot lead to signiﬁcant increases in un-
characteristically long-lived TCR-pMHC interactions. Most im-
portantly, both the B3K506 and B3K508 T cells demonstrate
enhanced activity to ligands with increasing t1/2. These data in-
dicate that for fast kinetic medium and strong KD ligands, T-cell
activation is negatively correlated with increasing numbers of
binding events.
Model and parameter sensitivity analysis. A. Model merging receptor occu-
pancy and dwell time. In the main text, we estimated parameters in
Eq. 1 to evaluate whether receptor occupancy and dwell time
models could jointly explain our data. Recent arguments suggest
that the relevant TCR concentration in Eq. 1 is the effective
concentration of TCRs in the synapse, averaged over TCR-rich
and TCR-sparse regions, assuming that the TCRs can move
freely between the two regions (6). Thus, the concentration of
TCRs in the interface between the T cell and APC, c0TCR, was
estimated in the main text by dividing the total number of TCRs
on a T cell (10,000 TCRs per T cell) by the total surface area of
a T cell (500 μm2), leading to an estimate of 20 TCRs per square
micrometer (7). Within TCR-rich regions (e.g., islands), c0TCR is
locally much higher (80–430 TCRs per square micrometer) (8).
Although we have used the lower effective concentration of
TCRs, higher concentrations would only improve the robustness
of our conclusions, as we demonstrate below.
To convert the measured KA of TCR-pMHC in solution to KA
when the TCR and pMHC are membrane-bound, we have used
a conﬁnement length measured for the 2B4 TCR interacting
with the MCC88-103 ligand (1.2 nm, corresponding to a con-
version factor of 0.262 nm) (7). Although this conversion has
precedent, it is uncertain, as recent research reveals (9, 10). The
need for more direct measurements of membrane kinetics has
long been acknowledged (11). In particular, one recent study of
pMHC-TCR kinetics on the membrane has suggested that kon
and koff are faster on the membrane than solution-based meas-
urements suggest and that actin-cytoskeleton-driven membrane
motion has a role in tearing apart bonds (10). The role of the
membrane in breaking apart bonds as short-lived as those in this
study is unclear.
Because the parameters involved in our models are uncertain,
we checked to determine if our conclusions were robust to pa-
rameter variations. First, we checked the validity of our con-
clusion that the receptor occupancy is saturated. To do so, we
varied the K*, modeling uncertainty both in the concentration of
TCRs on the T cell and in likely errors in converting SPR-
measured afﬁnities to afﬁnities on the membrane (Fig. S6). If the
threshold KD is weaker than our estimate, even weakly binding
peptides will almost always be bound and the conclusion is ro-
bust. As the threshold KD becomes much stronger than our es-
timate, some of the weaker binding peptides in our sample
become unsaturated. Even in these cases, however, it is unlikely
that changes in the KD could compensate for changes in the t1/2
in a merged receptor occupancy/dwell time model. The dwell
time depends strongly (exponentially) on the t1/2, whereas the
receptor occupancy depends weakly (sublinearly) on the KD,
even if the system is not saturated (see the arguments in the tests
of the pure afﬁnity model).
B. Rebinding. B1. Model sensitivity. In the main text, we applied Bell’s
model (12) to estimate the importance of rebinding on the
membrane. Here, we brieﬂy motivate rebinding models to suggest
that our qualitative conclusions are robust to the choice of model.
Once a ligand and receptor debind, we assume that there is
some probability they will rebind within a given time interval.
Suppose we knew this probability (p). The number of rebindings
would then be a geometrically distributed random variable with
parameter 1−p, assuming that every rebinding is independent,
and the expected number of rebindings would be p/(1−p).
What is the probability p? Clearly, it depends on the time
interval over which rebindings are counted. In the case of the
interaction between TCRs and pMHCs, we are only interested in
those rebindings that occur relatively quickly, before the TCR
signaling complex disassembles. Because it is unclear how quickly
the TCR signaling complex disassembles, however, models must
choose a different measure of “quickness.” (Analytically, other
measures are also more tractable.) One reasonable approach is
to count only those rebindings that occur before the pMHC
binds to another TCR for the ﬁrst time.
In a different approach, Bell’s model (12) can be interpreted to
count only those rebindings that occur almost immediately, before
the receptor and ligand are ever separated by more than a mo-
lecular distance. To see this, consider the probability that
a pMHC binds to a TCR before diffusing away when it is within
a molecular distance of the TCR. For simplicity, we canmodel the
reaction and diffusion as competing exponential processes with
rates corresponding to their characteristic rates, which scale as
kon/L
2 and D/L2, respectively, where L is the molecular distance.
(Note that kon is expressed on a per molecule basis.) Applying this
simple analysis to determine the probability p (13), it is possible to
obtain Bell’s model (12) (Eq. 2), within a constant factor.
How sensitive are the conclusions to the particular choice of
model? Clearly, the choice of which rebindings to count will affect
the quantitative results. Allowing more time for the pMHC and
TCR pair to rebind, for example, will lead to larger predictions
for the ta. The qualitative prediction of the model, however, is
robust. Independent of the choice of model, the ta will depend
on the t1/2 and KD when kon are low or high, respectively, and
on a combination of the two when kon are intermediate. The
robustness of this conclusion stems from the fact that it can
be motivated independently by simple arguments. When kon
are slow, rebinding will not occur and the ta will depend on
the single-interaction t1/2. Conversely, when kon are fast, a
pMHC and a TCR will rebind many times, essentially equili-
brating. As a result, the ta will depend only on the KD when kon
are large.
B2. Parameter estimates and sensitivity. To evaluate whether rebinding
could have an impact on the dwell time of B3K506 or B3K508
TCRs engaging IAb/3K and APL ligands, we estimated the pa-
rameters in Eq. 2. The diffusivity for a TCR and a pMHC was
estimated using published experimental measurements. We used
0.04 and 0.02 μm2/s as typical estimates of the diffusivities of
a pMHC (14–16) and a TCR, respectively (17–19). The range of
reported diffusivities is from 0.01 to 0.1 μm2/s for pMHCs, with
measurements concentrated toward the lower end, and from 0.01
to 0.12 μm2/s for TCRs, although the higher estimates may apply
to TCRs outside lipid rafts. We converted our SPRmeasurements
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of kon to kon on the membrane by assuming that afﬁnities on the
membrane are proportional to SPR-measured afﬁnities, as in our
analysis of receptor occupancy, and, further, by assuming that koff
on the membrane are identical to those measured by SPR. Be-
cause of limited data, it is generally difﬁcult to convert SPR-
measured kon to kon on the membrane (11, 20). A recent study of
pMHC-TCR kinetics on themembrane has suggested that kon and
koff are faster on the membrane than solution-based measure-
ments suggest and that actin-cytoskeleton-driven membrane
motion has a role in tearing apart bonds (10). The role of the
membrane in breaking apart bonds as short-lived as those in this
study is unclear. Additionally, because faster kon promote re-
binding but membrane motion driving the pair apart inhibits re-
binding, it is too early to understand how our qualitative results
would be affected.
Because of the uncertainty in these parameters, we checked the
robustness of our conclusion that rebinding explains the potency
of the peptides in our dataset. To do so, we varied the threshold
for rebinding, kon*, which models uncertainties in the diffusivities
of the TCR and the pMHC and errors in converting SPR-mea-
sured kon to kon on the membrane. It is also a rough way of
accounting for other factors that might increase or decrease the
likelihood of rebinding, such as membrane motion, as well as
uncertainty in the model itself. Threefold differences in the
threshold kon do not qualitatively affect our conclusions (Figs. S5
and S7). As the threshold for rebinding increases, rebindings
become less likely for any given pMHC-TCR pair and the effect
of rebinding on the ta weakens. As long as the rebinding
threshold falls within or near the range of kon in our data, it will
explain at least part of the difference between the B3K506 and
B3K508 TCRs, balancing their KD and t1/2.
Independent of the parameter estimates, we also provided best-
ﬁt values in the main text, which, being close to our estimates,
reinforced our conclusions. We provide another type of best-ﬁt
analysis, based on ﬁtting the models to groups of peptides with
similar activity, in Fig. S8 to show this conclusion in another way.
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Fig. S1. B3K506 and B3K508 TCRs interact with IAb/3K and peptide variants with differing rates of association and disassociation. The afﬁnity and kinetics of
soluble monomeric IAb-3K or variant peptide ligands binding to immobilized B3K506 and B3K508 TCRs were analyzed by SPR using BIAcore 2000 and BIAcore
3000 instruments (BIAcore AB). Approximately 2,000 resonance units (RU) of soluble B3K506 TCR was captured on the surface of a CM5 biosensor ﬂow cell by
an immobilized anti-Cα mAb, ADO-304. For the B3K506 T cells, soluble IAb/3K or variant peptides were injected at 20 μL/min for 60 s through a CM5 biosensor
ﬂow cell at a concentration of 3K WT (4, 8, 16, and 32 μM) (A), P5R (5.6, 11.2, 22.5, and 45 μM) (B), P8R (8, 16, 32, and 64 μM) (C), P-1A (8, 16, 32, and 64 μM) (D),
P8A (8, 16, 32, and 64 μM) (E), P-1K (12.9, 25.7, and 51.4 μM) (F), P8Q (13, 26, and 52 μM) (G), P-1L (16, 32, and 64 μM) (H), P8L (4, 8, 16, and 32 μM) (I), and P2A
(4, 8, 16, and 32 μM) (J). No speciﬁc binding was detected for the P3A, P5A, and P5Q ligands interacting with the B3K506 TCR. For the B3K508 T cells, soluble
IAb/3K or variant peptides were injected at 20 mL/min for 60 s through a CM5 biosensor ﬂow cell at a concentration of 3K WT (4, 8, 16, and 32 μM) (K), P5R (5.6,
11.2, 22.5, and 45 μM) (L), and P2A (4, 8, 16, and 32 μM) (M). Limited binding was detected for the P5A ligand binding the B3K508 TCR at 32 and 64 μM. No
speciﬁc binding was detected for the P-1A, P8R, P8A, and P3A ligands interacting with the B3K508 TCR. As a control for bulk ﬂuid phase refractive index, the
IAb-3K preparations were also injected through a fourth ﬂow cell with an immobilized irrelevant TCR Ani 2.3 speciﬁc for HLA-DR52c. All samples reached
equilibrium binding within 10 s. The complex was allowed to dissociate for 60 s between injections. Raw data were corrected for the bulk signal from buffer
and IAb-3K by performing identical injections through a ﬂow cell in which an irrelevant TCR was immobilized. The data were further corrected for the loss of
captured TCR during the series of injections based on the observed koff of the TCR from the anti-CαmAb (∼4.5 × 10−4 per second). The data were analyzed with
BIAcore Bioeval 4.1 software.
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Fig. S2. C57BL/6, B3K506, and B3K508 CD4+ T cells down-regulate TCR expression and up-regulate CD69 expression equivalently in response to titrating
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analyzed by ﬂow cytometry for TCR-β expression (A) and CD69 expression (B). TCR-β expression is normalized for each T-cell population to the expression at
which no activation occurs. Data are the average of three wells per variability and are representative of two independent experiments.
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Fig. S3. B3K506 and B3K508 T cells down-regulate TCR expression and produce TNF-α when challenged with high, medium, and low KD ligands. Naive B3K506
CD4 T cells down-regulate TCR expression (A) and produce TNF-α to 3K and APL ligands (B). Peptide ligands are listed by decreasing KD, with the 3K peptide
having the strongest KD and the P5Q peptide having the weakest (undetectable) KD. Naive B3K508 CD4 T cells down-regulate TCR expression (C) and produce
TNF-α to 3K and APL ligands (D). Peptide ligands are listed by decreasing KD. Data are representative of at least three independent experiments.
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Fig. S4. Evaluating models that correlate ligand potency with the number of long-lived bonds between pMHCs and TCRs. (A) Model merging receptor oc-
cupancy and dwell time does not explain the activities of the pMHC-TCR pairs. The pMHC-TCR pairs are ranked according to the average number of interactions
between them, at any given time, that have lasted longer than 2 s This average number was calculated as the product of two quantities: (i) the fraction of
peptides bound at any given time, as given in Eq. 1, and (ii) the fraction of such bindings that lasts longer than 2 s, assuming exponentially distributed binding
times. The result has been normalized by the B3K508 peptide interacting with the 3K peptide, which is predicted to be the most active. The results are fairly
insensitive to the parameter estimates because of the strong (exponential) dependence on the t1/2 and the weak (sublinear) dependence on the afﬁnity. (B and
C) Model merging serial triggering and dwell time does not explain the activities of the pMHC-TCR pairs. The pMHC-TCR pairs are ranked according to the
number of distinct interactions between them that last longer than a threshold time. The number of interactions is normalized by the number of interactions
for the B3K506 TCR interacting with the 3K peptide, which is predicted to be most active. The threshold time required to activate a TCR is assumed to be 2 s (B)
and 34 s (C). (C) Note that this panel is on a log scale.
Fig. S5. Determining the optimal rebinding threshold for the data. The variation in tas within groups of similar activity is plotted against different rebinding
thresholds for the most potent group of peptides (A) and the second most potent group of peptides (B). The optimal thresholds are 60,000/M·s (A) and 45,000/
M·s (B).
Fig. S6. Sensitivity of receptor occupancy to parameter estimates. The predicted receptor occupancy for each pMHC-TCR pair is plotted, according to Eq. 1,
using a K* of 130 μM as estimated in the main text (A) and with a K* three times stronger (43 μM) (B) and three times weaker (390 μM) (C). The different K*s
model uncertainty in the concentration of TCRs on the surface of the cell and the conversion between SPR-measured afﬁnities and afﬁnities on the membrane.
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Fig. S7. Sensitivity of rebinding to parameter estimates. Correlations between peptide potency and the ta are plotted with a rebinding threshold, kon*, of
60,000/M·s (A), as estimated in the main text, and with rebinding thresholds three times lower (20,000/M·s) (B) and three times higher (180,000/M·s) (C). The tas
were determined according to Eq. 2. The different rebinding thresholds model uncertainty in the diffusivities of the pMHCs and TCRs and the conversion
between SPR-measured kon and kon on the membrane.
Fig. S8. Models are compared according to their ability to account for peptides with equal activity but different afﬁnities, kon, and t1/2s. (A) Models are ﬁt to
the most potent group of peptides, which all have similar potency. The vertical, horizontal, and diagonal lines correspond to best-ﬁts for the t1/2, afﬁnity, and
rebinding models, respectively. (B) Models are ﬁt to the second most potent group of peptides. The best-ﬁts for the rebinding model correspond to rebinding
thresholds, kon, of 32,000/M·s (A) and 45,000/M·s (B). These are similar to the best-ﬁts obtained using the techniques in Fig. S5.
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Table S1. TCR-ligand KD, binding kinetics, and T-cell effector functions
TCR
IAb + 3K
mutation
KD
(μM)
kon
(1/M·s)
koff
(1/s)
t1/2
(s)
Proliferation
EC50 (nM)
TNF-α
EC50
(nM)
B3K506 WT 7 101,918 0.7 0.9 0.2 3.1
B3K506 P5R 11 74,654 0.8 0.9 0.2 6
B3K506 P8R 13 64,318 0.8 0.8 0.3 7
B3K506 P-1A 26 101,731 2.6 0.3 9 68
B3K506 P8A 92 33,370 3.1 0.2 1,200 2,210
B3K506 P-1K 101 55,149 5.6 0.1 660 5,500
B3K506 P8Q 114 ND >5 <0.2 9,800 >10,000
B3K506 P-1L 122 ND >5 <0.2 710 3,600
B3K506 P8L 256 ND >5 <0.2 >10,000 >10,000
B3K506 P2A 278 ND >5 <0.2 750 5,500
B3K506 P3A >550 ND ND ND >10,000 >10,000
B3K506 P5A >550 ND ND ND >10,000 >10,000
B3K506 P5Q >550 ND ND ND >10,000 >10,000
B3K508 WT 29 10,887 0.3 2.2 0.4 6
B3K508 P5R 93 11,048 1.0 0.7 15 87
B3K508 P2A 175 19,914 3.5 0.2 71 530
B3K508 P5A >550 ND ND ND 5,700 >10,000
B3K508 P-1A >550 ND ND ND >10,000 >10,000
B3K508 P8R >550 ND ND ND 980 >10,000
B3K508 P8A >550 ND ND ND >10,000 >10,000
B3K508 P3A >550 ND ND ND >10,000 >10,000
Scatchard analysis of binding data data were used to determine the dissociation constant (KD). The kon was calculated from the KD and koff (kon = koff/KD).
The t1/2 values were calculated using ﬁrst-order reaction kinetics: t1/2 = ln(2)/koff. ND, not determined.
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